These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24649303)

  • 21. Establishment of novel mAb to human ERC/mesothelin useful for study and diagnosis of ERC/mesothelin-expressing cancers.
    Ishikawa K; Segawa T; Hagiwara Y; Maeda M; Abe M; Hino O
    Pathol Int; 2009 Mar; 59(3):161-6. PubMed ID: 19261093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of urinary mesothelin in patients with malignant mesothelioma.
    Creaney J; Musk AW; Robinson BW
    J Thorac Oncol; 2010 Sep; 5(9):1461-6. PubMed ID: 20815094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model.
    Yoshida C; Sogawa C; Tsuji AB; Sudo H; Sugyo A; Uehara T; Hino O; Yoshii Y; Fujibayashi Y; Fukumura T; Koizumi M; Arano Y; Saga T
    Nucl Med Commun; 2010 May; 31(5):380-8. PubMed ID: 20072072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos.
    Filiberti R; Marroni P; Spigno F; Merlo DF; Mortara V; Caruso P; Cioè A; Michelazzi L; Bruzzone A; Bobbio B; Simonassi C; Del Corso L; Galli R; Racchi O; Dini G; Linares R; Mencoboni M
    Oncology; 2014; 86(1):33-43. PubMed ID: 24401539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesothelin-family proteins and diagnosis of mesothelioma.
    Robinson BW; Creaney J; Lake R; Nowak A; Musk AW; de Klerk N; Winzell P; Hellstrom KE; Hellstrom I
    Lancet; 2003 Nov; 362(9396):1612-6. PubMed ID: 14630441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma.
    Pantazopoulos I; Boura P; Xanthos T; Syrigos K
    Eur Respir J; 2013 Mar; 41(3):706-15. PubMed ID: 22835614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In commemoration of the 2018 Mataro Nagayo Prize: A road to early diagnosis and monitoring of asbestos-related mesothelioma.
    Hino O; Abe M; Han B; Yan Y
    Cancer Sci; 2019 May; 110(5):1518-1524. PubMed ID: 30888083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expression.
    Kojima M; Kajino K; Momose S; Wali N; Hlaing MT; Han B; Yue L; Abe M; Fujii T; Ikeda K; Hino O
    Respir Res; 2020 Jul; 21(1):187. PubMed ID: 32677949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MESOMARK kit detects C-ERC/mesothelin, but not SMRP with C-terminus.
    Segawa T; Hagiwara Y; Ishikawa K; Aoki N; Maeda M; Shiomi K; Hino O
    Biochem Biophys Res Commun; 2008 May; 369(3):915-8. PubMed ID: 18328258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer.
    Muley T; Dienemann H; Herth FJ; Thomas M; Meister M; Schneider J
    J Thorac Oncol; 2013 Jul; 8(7):947-51. PubMed ID: 23777840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.
    Creaney J; Yeoman D; Demelker Y; Segal A; Musk AW; Skates SJ; Robinson BW
    J Thorac Oncol; 2008 Aug; 3(8):851-7. PubMed ID: 18670302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.
    Bayram M; Dongel I; Akbaş A; Benli I; Akkoyunlu ME; Bakan ND
    Lung; 2014 Feb; 192(1):197-203. PubMed ID: 24170217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual predictors of increased serum mesothelin in asbestos-exposed workers.
    Filiberti R; Marroni P; Mencoboni M; Mortara V; Caruso P; Cioè A; Michelazzi L; Merlo DF; Bruzzone A; Bobbio B; Del Corso L; Galli R; Taveggia P; Dini G; Spigno F
    Med Oncol; 2013 Mar; 30(1):422. PubMed ID: 23277285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and pleural fluid biomarkers for mesothelioma.
    Creaney J; Robinson BW
    Curr Opin Pulm Med; 2009 Jul; 15(4):366-70. PubMed ID: 19417672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
    Creaney J; Robinson BW
    Hematol Oncol Clin North Am; 2005 Dec; 19(6):1025-40, v. PubMed ID: 16325121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin.
    Ak G; Tada Y; Shimada H; Metintas S; Ito M; Hiroshima K; Tagawa M; Metintas M
    BMC Cancer; 2017 Mar; 17(1):212. PubMed ID: 28335760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of screening for malignant pleural mesothelioma.
    Pass HI; Carbone M
    Semin Thorac Cardiovasc Surg; 2009; 21(2):97-104. PubMed ID: 19822280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma.
    Santarelli L; Staffolani S; Strafella E; Nocchi L; Manzella N; Grossi P; Bracci M; Pignotti E; Alleva R; Borghi B; Pompili C; Sabbatini A; Rubini C; Zuccatosta L; Bichisecchi E; Valentino M; Horwood K; Comar M; Bovenzi M; Dong LF; Neuzil J; Amati M; Tomasetti M
    Lung Cancer; 2015 Dec; 90(3):457-64. PubMed ID: 26431916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of renal failure on the tumor markers of mesothelioma, N-ERC/mesothelin and osteopontin.
    Shiomi K; Shiomi S; Ishinaga Y; Sakuraba M; Hagiwara Y; Miyashita K; Maeda M; Suzuki K; Takahashi K; Hino O
    Anticancer Res; 2011 Apr; 31(4):1427-30. PubMed ID: 21508397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The N-ERC index is a novel monitoring and prognostic marker for advanced malignant pleural mesothelioma.
    Mori T; Tajima K; Hirama M; Sato T; Kido K; Iwakami S; Sasaki S; Iwase A; Shiomi K; Maeda M; Hino O; Takahashi K
    J Thorac Dis; 2013 Apr; 5(2):145-8. PubMed ID: 23585940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.